ATE354802T1 - Methoden zum screening knochenmorphogenetishemimetika - Google Patents

Methoden zum screening knochenmorphogenetishemimetika

Info

Publication number
ATE354802T1
ATE354802T1 AT00992674T AT00992674T ATE354802T1 AT E354802 T1 ATE354802 T1 AT E354802T1 AT 00992674 T AT00992674 T AT 00992674T AT 00992674 T AT00992674 T AT 00992674T AT E354802 T1 ATE354802 T1 AT E354802T1
Authority
AT
Austria
Prior art keywords
methods
agents
morphogenetishemimetics
screening bone
daf
Prior art date
Application number
AT00992674T
Other languages
English (en)
Inventor
Dattatreymurty Bosukonda
Original Assignee
Thrasos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrasos Inc filed Critical Thrasos Inc
Application granted granted Critical
Publication of ATE354802T1 publication Critical patent/ATE354802T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
AT00992674T 2000-11-06 2000-12-07 Methoden zum screening knochenmorphogenetishemimetika ATE354802T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24623100P 2000-11-06 2000-11-06

Publications (1)

Publication Number Publication Date
ATE354802T1 true ATE354802T1 (de) 2007-03-15

Family

ID=22929832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00992674T ATE354802T1 (de) 2000-11-06 2000-12-07 Methoden zum screening knochenmorphogenetishemimetika

Country Status (8)

Country Link
US (3) US20040009532A1 (de)
EP (1) EP1334365B1 (de)
AT (1) ATE354802T1 (de)
AU (1) AU2001245209A1 (de)
CA (1) CA2431552A1 (de)
DE (1) DE60033576T2 (de)
ES (1) ES2282163T3 (de)
WO (1) WO2002039118A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026277A2 (en) * 1996-01-22 1997-07-24 Creative Biomolecules, Inc. Morphogen analogs and methods for producing them
US20030185792A1 (en) * 1996-01-22 2003-10-02 Curis, Inc. Morphogen analogs of bone morphogenic proteins
WO2003070749A2 (en) 2002-02-15 2003-08-28 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
WO2003106656A2 (en) * 2002-06-17 2003-12-24 Thrasos, Inc. Single domain tdf-related compounds and analogs thereof
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
WO2005037232A2 (en) 2003-10-17 2005-04-28 Joslin Diabetes Center, Inc. Methods and compositions for modulating adipocyte function
US7544661B2 (en) * 2003-12-05 2009-06-09 Northwestern University Self-assembling peptide amphiphiles and related methods for growth factor delivery
US8410246B2 (en) 2004-06-17 2013-04-02 Thrasos, Inc. TDF-related compounds and analogs thereof
EP1847265A4 (de) * 2005-01-26 2008-04-30 Mian Long Verwendung on flavonol und flavonolglykosiden zur stimulierung des wachstums renal-tubulärer epithelzellen zur sezernierung des nierensezernierenden knochenwachstumsfaktors
WO2006130690A2 (en) 2005-06-01 2006-12-07 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
DK2497780T3 (en) 2005-09-20 2015-06-01 Thrasos Innovation Inc TDF-related compounds and analogs thereof
US8076295B2 (en) 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
WO2009045321A1 (en) * 2007-09-28 2009-04-09 Stryker Corporation Methods for detecting neutralizing antibodies for bone morphogenetic proteins
MX2011010780A (es) 2009-04-13 2011-10-28 Univ Northwestern Andamios novedosos basados en peptido para la regeneracion de cartilagos y metodos para su uso.
KR102749109B1 (ko) * 2021-11-04 2025-01-03 (주)케어젠 생리 활성을 갖는 펩타이드 및 그의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
US6248554B1 (en) * 1993-11-24 2001-06-19 The Procter & Gamble Company DNA sequence coding for a BMP receptor
EP0756628B1 (de) * 1994-04-29 2007-11-14 Curis, Inc. Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
AU2404695A (en) * 1994-05-04 1995-11-29 Mount Sinai Hospital Corporation Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same
US6083690A (en) * 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
US6190659B1 (en) * 1996-09-17 2001-02-20 The Rockefeller University Bacterial plasmin binding protein and methods of use thereof
WO2000061774A2 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. Bone morphogenic proteins

Also Published As

Publication number Publication date
US20110081662A1 (en) 2011-04-07
CA2431552A1 (en) 2002-05-16
EP1334365A1 (de) 2003-08-13
AU2001245209A1 (en) 2002-05-21
US20040009532A1 (en) 2004-01-15
DE60033576T2 (de) 2007-10-31
EP1334365B1 (de) 2007-02-21
ES2282163T3 (es) 2007-10-16
WO2002039118A1 (en) 2002-05-16
WO2002039118A8 (en) 2002-12-27
DE60033576D1 (de) 2007-04-05
US20090124537A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
DE60033576D1 (de) Methoden zum screening knochenmorphogenetishemimetika
ATE380187T1 (de) Agonisten und antagonisten für den lpa-rezeptor und anwendungsmethoden
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
NO983431L (no) Anti-klöemidler
NO20042964L (no) Spiroazasykliske forbindelser som monoaminreseptormodulatorer
EP1267616A4 (de) Verfahren zur modulation des haarwuchses
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
ATE349434T1 (de) Lactamderivaten zur verwendung als humane 11cby rezeptorantagonisten
ATE322258T1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
ATE288747T1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
EP1017713A4 (de) ZYKLISCHE AGONISTEN UND ANTAGONISTEN DER C5a REZEPTOREN SOWIE G-PROTEIN GEKOPPELTEN REZEPTOREN
TW200607814A (en) Cell surface receptor isoforms and methods of identifying and using the same
DE69400824D1 (de) Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne
WO2003068944A3 (en) METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α-
NO20061845L (no) Fenyl-piperazinderivater som modulatorer for muskarine reseptorer
WO2005117968A3 (en) Compositions and methods comprising an egfl7 antagonist for modulating vascular development
DE69935670D1 (de) Behandlung von dyskinesie durch mu-selektive opioidantagonisten
YU17503A (sh) Receptor oblasti (ii) edb-fibronektina
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
ATE269085T1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
EA200700951A1 (ru) БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG
DK0900218T3 (da) Heterocykliske forbindelser
ATE545866T1 (de) Liganden von g-protein-gekoppelten rezeptoren und verfahren
CY1110278T1 (el) Μεθοδος διαλογης παραγοντων ικανων να θεραπευουν την παχυσαρκια
GB0213698D0 (en) Receptor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1334365

Country of ref document: EP

REN Ceased due to non-payment of the annual fee